About US
Contact us
-
Ironwood, Allergan's new Linzess pain data could cue much-needed prescription jumpIronwood and Allergan have long pinned hopes for IBS drug Linzess on getting patients to switch from over-the-counter remedies to treat constipation. New pain and bloating data for Linzess could help2019/6/21
-
Amphastar squeezes partners Momenta, Sandoz for $60M in Lovenox settlementSanofi’s big-selling blood thinner Lovenox has long faced generic competition in the U.S., but now rival generics makers are squashing long-running lawsuits over their own versions of the drug. Part2019/6/20
-
AstraZeneca's COPD triplet Breztri, rival to GSK's Trelegy, nabs first nod from JapanAs AstraZeneca tussles with British compatriot GlaxoSmithKline in the respiratory arena, it has nabbed its first global approval for Breztri Aerosphere, a three-in-one COPD inhaler that could rival G2019/6/20
-
Merck scouts replacements for CEO Frazier less than a year after scrapping retirement rule: reportIt was less than a year ago that Merck’s board scrapped a policy that CEOs must retire at the age of 65 in a move designed to keep Ken Frazier around longer. Now, the company is scouting replacemen2019/6/19
-
Roche's Floodlight MS app mines 'hidden' data to advance disease mappingCANNES, FRANCE—Multiple sclerosis symptoms can be confusing: They differ person to person, and even day to day for the same patients. Roche's Floodlight Open app aims to clear that confusion for indi2019/6/19
-
Merck's Keytruda gives BMS' Opdivo some company with small cell lung cancer nodBristol-Myers Squibb's FDA approval for Opdivo in patients with previously treated small cell lung cancer (SCLC) already has looked shaky since the drugfailed to extend patients' lives in a phase 3 t2019/6/18
-
Bayer: Roche scores first global nod for targeted cancer drug RozlytrekAs cancer treatment continues a march toward increasingly targeted therapies, Roche has secured its first global approval for Rozlytrek, a med designed to fight NTRK fusion-positive tumors and one2019/6/18
-
China's Fosun rallies support for a joint bid for Bayer's animal health unit: reportAs Bayer management predicted, it seems as though the German conglomerate’s for-sale animal health business has indeed attracted high interest. China’s Fosun International, parent of Fosun Pharma, is2019/6/17
-
Sanofi, Google team up in search of new treatments, marketing solutionsA few months ago, Sanofi tapped its chief medical officer Ameet Nathwani, M.D., to spearhead a digital revolution at the company. And he’s bringing in the big guns to help. The French drugmaker hasjo2019/6/17
-
Pfizer's Xeljanz matches immunosuppressant combo in rheumatoid arthritis studyPfizer’s troubled JAK inhibitor Xeljanz has had its share of hiccups after pulmonary embolism fears derailed the drug’s higher dose in rheumatoid arthritis. Now, Pfizer is hoping for better results u2019/6/14